Effects of fibrates on serum lipids and atherosclerosis
- 1 January 1988
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 37 (2) , 167-191
- https://doi.org/10.1016/0163-7258(88)90024-1
Abstract
No abstract availableThis publication has 150 references indexed in Scilit:
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983
- High-density lipoprotein subfractions in normolipidemic patients with coronary atherosclerosis.Circulation, 1982
- Epidemiology as a Guide to Clinical DecisionsNew England Journal of Medicine, 1980
- Lipoprotein Lipase: Some Effects of Activator ProteinsEuropean Journal of Biochemistry, 1980
- Increase in Lipoprotein Lipase during Clofibrate Treatment of Hypertriglyceridemia in Patients on HemodialysisNew England Journal of Medicine, 1979
- Platelet kinetic studies in patients with hyperlipoproteinemia: effects of clofibrate therapy.Circulation, 1979
- Clinical Pharmacokinetics of Hypolipidaemic DrugsClinical Pharmacokinetics, 1978
- Effect of clofibrate on intravascular coagulation in hyperlipoproteinemia.Circulation, 1977
- Long-Term Effects of Clofibrate (Atromid-S) on Serum Lipids in ManCirculation, 1969
- Ischemic Heart Disease, Atherosclerosis, and LongevityCirculation, 1966